Repositioning niclosamide and alectinib to inhibit the hyperphosphorylation of SARS‐CoV‐2's nucleocapsid protein

Song Chen, Zunyu He, Jean Kanyo, TuKiet Lam, Grace Ha, Brett Lindenbach, Ya Ha

Open source

DOI
10.1111/bph.70679
Published
2026-09-24
Container
British Journal of Pharmacology
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/bph.70679,
  title = {Repositioning niclosamide and alectinib to inhibit the hyperphosphorylation of SARS‐CoV‐2's nucleocapsid protein},
  author = {Song Chen and Zunyu He and Jean Kanyo and TuKiet Lam and Grace Ha and Brett Lindenbach and Ya Ha},
  year = {2026},
  journal = {British Journal of Pharmacology},
  doi = {10.1111/bph.70679},
  url = {https://doi.org/10.1111/bph.70679}
}

RIS

TY  - JOUR
TI  - Repositioning niclosamide and alectinib to inhibit the hyperphosphorylation of SARS‐CoV‐2's nucleocapsid protein
AU  - Song Chen
AU  - Zunyu He
AU  - Jean Kanyo
AU  - TuKiet Lam
AU  - Grace Ha
AU  - Brett Lindenbach
AU  - Ya Ha
PY  - 2026
JO  - British Journal of Pharmacology
DO  - 10.1111/bph.70679
UR  - https://doi.org/10.1111/bph.70679
ER  - 

APA

Chen, S., He, Z., Kanyo, J., Lam, T., Ha, G., Lindenbach, B., & Ha, Y. (2026). Repositioning niclosamide and alectinib to inhibit the hyperphosphorylation of SARS‐CoV‐2's nucleocapsid protein. British Journal of Pharmacology. https://doi.org/10.1111/bph.70679

Source records